South Africa Extends Vaccinations To Under-50s Amid Covid Surge

0

With more than 2.1 million detected COVID-19 cases, South Africa accounts for 37% of Africa’s infections, according to Africa Centres for Disease Control and Prevention.

South Africa Extends Vaccinations To Under-50s Amid Covid Surge

Four million of South Africa’s 59 million population have received at least first dose of COVID vaccine.



Johannesburg:

South Africa announced Friday it would start vaccinating people under 50 years old as the continent’s hardest-hit country buckles under a vicious third wave of COVID-19 infections driven by the Delta variant. The decision comes just two weeks after the government extended the country’s struggling vaccination campaign under 60s.

“We are aiming to start vaccinating the 35 to 49 age group from August 1,” acting Health Minister Mmamoloko Kubayi-Ngubane told a weekly media briefing.

With more than 2.1 million detected coronavirus cases, South Africa accounts for 37 per cent of the continent’s infections, followed far behind by Morocco and Tunisia with nine and eight per cent respectively, according to the Africa Centres for Disease Control and Prevention.

And infections are rapidly rising, with a pandemic-high 26,485 recorded on Saturday alone. On Thursday, it saw 22,910 new cases and 460 deaths, taking its total number of fatalities to 63,499.

Leading virologist Tulio de Oliveira told the briefing that the highly contagious Delta variant “is still fast spreading” in the country.

“We are not out the woods,” he said. “What’s happening in South Africa is happening is many countries that still have low vaccination rates.”

Around four million of South Africa’s 59 million population have received at least a first dose at one of nearly 2,600 vaccination sites.

“We have reached 5.6 per cent of the population, obviously way too little to reach heard immunity,” said Nicholas Crisp, the health ministry’s deputy director-general.

The government recently approved the use of Chinese vaccines Sinovac and Sinopharm, which joined the Pfizer-BioNTech and Johnson & Johnson jabs in the country’s rollout.

It is targeting a rate of 250,000 vaccinations daily.

(Except for the headline, this story has not been edited by our staff and is published from a syndicated feed.)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

All the data shown above will be stored by www.rajpostexam.com on https://www.rajpostexam.com/. At any point of time, you can contact us and select the data you wish to anonymise or delete so it cannot be linked to your email address any longer. When your data is anonymised or deleted, you will receive an email confirmation. We also use cookies and/or similar technologies to analyse customer behaviour, administer the website, track users' movements, and to collect information about users. This is done in order to personalise and enhance your experience with us. Click here to read our Cookie Policy.